The projected outcome of a specific treatment is referred to as the outcome. The stage and kind of cancer, the treatment offered, the patients' age, tolerance, and overall health are all factors that influence the outcome. It also differs from person to person. One of the metrics connected to outcome is the five-year cancer survival rate, which is expressed as a percentage and represents the number of patients who have survived cancer using anticancer therapy. Out of every 100 people diagnosed with cancer, this is the number of patients who have survived the disease for more than five years.
The following are the outcomes of the skin cancer treatments:
It is a treatment for skin cancer that involves the use of anticancer medicines. These medications are prescribed in cycles. Patients are given a rest period after each cycle to help them manage and cope with the negative effects. These medications are absorbed by the blood and virtually move across the body with the blood, killing cancer cells in all parts of the body.
- Surgical methods
They are the most commonly suggested skin cancer therapies. Surgical techniques alone are capable of healing localised skin cancers, while it is utilised as part of the major treatment for advanced skin cancers. The procedure entails the removal of the upper layers of the skin as well as the surrounding tissues.
It uses high-energy X-rays to kill skin cancer cells and tumours. The goal of this treatment is to eliminate cancer cells while also limiting their proliferation. In the treatment of skin cancer, radiotherapy has a high success rate. The treatment's effectiveness is improved by using a higher and more accurate dose of radiation.
- Photodynamic therapy (PDT)
It is a treatment that uses a specific type of laser light to treat skin cancer. It's frequently given with other medications that are inert until they're exposed to laser light. These medications are administered intravenously or topically and accumulate more in cancer cells than in normal cells. The most significant downside of this treatment is the harm it does to healthy cells.
- Chemical peel,
Its objective is to enhance the skin's appearance.It's done by smearing a chemical solution over the damaged areas and allowing it to permeate through the top layers of the skin. Actinic keratosis is commonly treated with them.
- Targeted therapy
It is a type of treatment that use medications that specifically target malignant cells. They avoid causing irreversible damage to the healthy cells that remain. Signal transduction inhibitors are utilised as part of targeted therapy. These inhibitors prevent signals from passing between molecules in cells, resulting in cell death.
Immunotherapy tries to strengthen the patient's immune system by restoring the body's fight against cancer by employing artificial chemicals. These medications are frequently injected into the skin. Biotherapy or biologic therapy is another name for this procedure.
Survival rates after treatment, by type and stage:
The five-year survival rate, which illustrates how many patients out of 100 live beyond five years after being diagnosed with a given malignancy, is commonly referred to as the survival rate. It's a metric for determining a patient's prognosis based on the type and stage of cancer.
Localized skin cancer has a 95 percent five-year survival rate, while metastasized skin cancer has a 25 percent five-year survival rate.
Melanoma accounts for only 1% of all skin cancers detected, but it is responsible for the majority of skin cancer mortality. The survival rates of various stages of melanoma are as follows:
- Stage I: The cancer is limited to the skin at this point.It hasn't migrated to any nearby lymph nodes.Melanoma stage I has a five-year survival rate of around 97 percent.
- Stage II: Skin cancer in this stage may have spread to surrounding tissues and into the dermis, but not beneath it. Melanoma stage II has a 92 percent five-year survival rate.
- Stage III: Melanoma in Stage III is a metastasized form of cancer that has spread to the deeper layers of the skin, as well as distant lymph nodes and organs. Stages IIIA and IIIB are less risky than stage IIIC, with survival rates of 78% and 59%, respectively, compared to 40% for stage IIIC.
- Stage IV: Melanoma has progressed to other regions of the body, such as the lymph nodes, lungs, liver, bones, or brain, at this stage. The most advanced phases of skin cancer are those in which the cancer has spread throughout the body. The five-year survival rate for stage IV melanoma is between 15% to 25%.
Non-melanoma skin cancers are among the most treatable types of skin cancer. Non-melanoma skin cancer accounts for 0-5 percent of all skin cancer deaths. Basal cell carcinoma has a nearly 100 percent five-year survival rate when detected early, while squamous cell carcinoma has a 95 percent five-year survival rate. Merkel cell cancer has an 85 percent five-year survival rate.